Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Enabling Genomic Technologies and Screening Asia

11 Sep 2014 - 12 Sep 2014 - Singapore, Asia



Bookmark and Share


Select Biosciences South East Asia is delighted to announce that our Enabling Genomic Technologies and Screening Asia Conference and Exhibition will take place at the Biopolis, Singapore on the 11th and 12th September 2014. 

We are co-hosting the event with The Genome Institute of Singapore (GIS) at A*STAR’s state of the art conference facilities within the Biopolis, the Biomedical Science hub for Singapore. 

The event will have two concurrent conference tracks, with presentations from the leading scientists within these fields. The first conference track will cover Enabling Genomic Technologies and we are proud to welcome Dr. Kosuke Yusa as our Keynote Speaker for the meeting. Dr. Kosuke Yusa is a member of the Sanger Institute Faculty, UK.

We are also pleased to welcome both Dr. Ramanuj DasGupta, Group Leader/Senior Investigator, GIS, Cancer Therapeutics & Stratified Oncology, Assoc. Professor, NYU Cancer Institute and Dr. Pauline Ng, Group Leader/Senior Investigator, GIS, Chief Informatics Officer, Polaris. They will be representing our partner, The Genome Institute Singapore (GIS).  

The second track is entitled Screening Asia and we are privileged to have Dr. Alex Matter, M.D., Professor David Virshup and Dr. Litao Zhang, as our Keynote Speakers. 

Dr. Matter is the CEO of the Experimental Therapeutics Centre, A*STAR, Singapore. Professor Virshup is the inaugural Director of the Cancer and Stem Cell Biology Program at the Duke-NUS Graduate Medical School in Singapore. Dr Litao Zhang is the Vice President of Leads Discovery and Optimization, Bristol-Myers Squibb.

Attending this meeting will give you an excellent opportunity for networking with like-minded peers, helping you to find unique solutions and build long term collaborations. With all delegates having full access to both conference tracks, everyone has the opportunity to develop the specific agenda of their choice. 

Select Biosciences South East Asia is looking forward to welcoming you to this exciting event, and we hope that your experience will be both informative and enjoyable.



Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.
Small Molecules Lead to a Big Change in Reaction Outcomes
Scientists have changed the behaviour of a group of molecules involved in carbon-oxygen bond synthesis.
Enhancing Antibiotics to Defeat Resistant Bacteria
Scientists enhance ability of antibiotics to defeat resistant types of bacteria using molecules called PPMOs
Sanger Institute, St Jude Data-Sharing Agreement
Childhood cancer targeted by Sanger Institute and St Jude Children’s Research Hospital exchanges of cancer data
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!